Ste Virbac Aktie [WKN: 874929 / ISIN: FR0000031577]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Ste Virbac SA

06.04.23		Virbac : Declaration of the number of shares and voting rights 03/2023 (GlobeNewswire)
23.03.23		Virbac : Public release of the Year-End Consolidated Accounts at 31 December 2022 (GlobeNewswire)
23.03.23		VIRBAC: 2022 current operating income on the rise at +8.3%, reflecting the momentum of our business over the year in a slowing market (GlobeNewswire)
03.03.23		Virbac : Declaration of the number of shares and voting rights 02/2023 (GlobeNewswire)
28.02.23		Virbac : Declaration of the number of shares and voting rights 01/2023 (GlobeNewswire)
18.10.22		VIRBAC: Revenue growth at end of September at +7.7% at comparable exchange rates and perimeter (+12.7% at actual rates (GlobeNewswire)
15.09.22		Virbac: increase in operating income in the first half of 2022 reflecting the dynamism of our business (GlobeNewswire)
19.07.22		VIRBAC: growth in revenue in the first half of 2022 of +12.0% at comparable exchange rates (+16.4% at real rates), driven by good performance in all areas (GlobeNewswire)
14.04.22		Virbac : Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good performance in all areas (GlobeNewswire)
22.03.22		VIRBAC: 2021 operating profit from ordinary activities showed very strong growth, reflecting the excellent dynamism of our business in a rapidly growing market (GlobeNewswire)
19.01.22		VIRBAC: Exceptional growth in annual revenue of +18.4% at comparable exchange rates and scope (+14.9% at constant rates and real scope), driven by remarkable performance in a very buoyant market (GlobeNewswire)
05.11.21		Virbac: Aquaculture - Virbac completes the acquisition of Centrovet (GlobeNewswire)
18.10.21		Virbac: excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance aga (GlobeNewswire)
15.09.21		Virbac: Significant increase in operating profit from ordinary activities for the first half of 2021 due to the sound market performance and dynamism of our business (GlobeNewswire)
13.09.21		Virbac : Aquaculture : Virbac strengthens its position in Centrovet (GlobeNewswire)
20.07.21		Virbac: Exceptional increase in revenue in the first half of 2021, with +21.3% at comparable exchange rates and scope (+14% at constant exchange rates and actual scope), driven by very solid performan (GlobeNewswire)
05.07.21		Virbac: driven by very solid performance in all areas and a very dynamic market, we are raising our outlook for 2021 (GlobeNewswire)
15.04.21		Virbac: very strong growth in revenue in the first quarter of 2021 at +22.6% at comparable exchange rates and scope (+12.3% at constant rates), driven by very solid performance in all areas (GlobeNewswire)
17.03.21		Virbac: 2020 current operating income showed strong growth (+37.6% at constant rates and scope), reflecting the excellent evolution of revenue (+5.7% at constant rates and scope) and a sharp decrease (GlobeNewswire)
17.03.21		Virbac 2020 Year-end consolidated accounts (GlobeNewswire)
19.01.21		VIRBAC:2020 annual revenue shows strong growth of +5.7% at constant exchange rates and scope (+3.2% at constant rates) (GlobeNewswire)
14.10.20		VIRBAC: Revenue grew +6.8% at constant exchange rates and scope at the end of September 2020 (+5.6% at constant rates) thanks to solid third quarter performance (GlobeNewswire)
13.10.20		Virbac will change its governance at its shareholders' meeting on December 15 (GlobeNewswire)
16.09.20		Virbac : Half-yearly financial report 2020 (GlobeNewswire)
16.09.20		VIRBAC: Operating profit from ordinary activities up sharply for the first half of 2020 reflecting revenue resiliency and strong expenditure restraint during the Covid-19 crisis (GlobeNewswire)
20.07.20		Virbac: Revenue grew by +5.0% at constant exchange rates in the first half of 2020 (+4.5% excluding Sentinel), impacted by a decline in the second quarter of the year (GlobeNewswire)
02.07.20		Virbac completes divestment of U.S. Rights to SENTINEL® brands to MSD Animal Health (GlobeNewswire)
13.05.20		Virbac to divest U.S. Rights to SENTINEL® brands to MSD Animal Health (GlobeNewswire)
30.04.20		Virbac Annual Report 2019 (GlobeNewswire)
15.04.20		Virbac: 2020 first quarter revenue rose by +14.3% at comparable exchange rates, significantly impacted by anticipatory buying (GlobeNewswire)
16.03.20		Virbac: 2019 operating profit from ordinary activities on the rise (GlobeNewswire)
16.01.20		Virbac: 2019 annual revenue shows strong growth of +6.6% at constant exchange rates (GlobeNewswire)
20.12.19		Virbac : the Group raises the 2019 annual outlook (GlobeNewswire)
15.11.19		Virbac : quarterly financial information as of September 30, 2019 (GlobeNewswire)
11.10.19		Virbac : solid +8.4% growth in revenue at constant exchange rates at the end of September, 2019 (GlobeNewswire)
16.09.19		Virbac : Half-yearly financial report 2019 (GlobeNewswire)
16.09.19		Virbac: operating profit on the rise in the first half of 2019 (GlobeNewswire)
16.07.19		Virbac : 2019 first half-year revenue grew by +6.6% at constant exchange rates (GlobeNewswire)
11.04.19		Virbac : 2019 first quarter revenue rose by +10.9% at comparable exchange rates (GlobeNewswire)
18.03.19		Virbac: 2018 operating profit from ordinary activities grew by 13.4% (GlobeNewswire)
17.01.19		Virbac : 2018 annual revenue grew by +4.5% at constant exchange rates (GlobeNewswire)
11.10.18		Virbac : revenue grew by +5.5% at constant exchange rates at the end of September 2018 (GlobeNewswire)
17.07.18		Virbac : Revenue grew by +4.3% at constant exchange rates in the second quarter of 2018 (GlobeNewswire)
12.04.18		Virbac : 2018 first quarter revenue rose by +3.3% at comparable exchange rates (GlobeNewswire)
14.03.18		Virbac : operating profit from ordinary activities 2017 comparable to 2016 (GlobeNewswire)
16.01.18		Virbac : annual sales comparable to 2016 at constant exchange rates after strong fourth-quarter growth (GlobeNewswire)
22.11.17		Virbac : Aquaculture: Virbac postpones its option to buy Centrovet for three years (GlobeNewswire)
12.10.17		Virbac: quarterly sales affected by distributor destocking in the United States (GlobeNewswire)
11.09.17		Virbac: slight increase in first half results (GlobeNewswire)
17.07.17		Virbac: second quarter sales growth largely offsets the decline in the first quarter (GlobeNewswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Neuer Rekord nicht mehr weit: Bitcoin, Ethereum, Litecoin & Co.: Wie sich die Kryptokurse am Mittag entwickeln

Pierer Mobility-Aktie zweistellig im Plus: Pierer dementiert Mateschitz-Einstieg bei KTM

Krypto-Update: Diese fünf Kryptowährungen stehen derzeit im Fokus

Bitcoin überholt Silber: Kryptowährung auf Rekordkurs

voestalpine-Aktie mit Verlusten: Stabile Erdgasversorgung trotz möglicher Unterbrechungen aus Russland

Diese Aktien empfehlen Experten zu kaufen

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	25.11.2024 18:40
Kaufwert:	EUR
	Hinzufügen Speichern